Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery Automation - Chemistry Automation & Compound Management

Mark Wigglesworth's Biography



Mark Wigglesworth, Manger, GlaxoSmithKline

Sorry, There is currently no biography for this presenter.

Mark Wigglesworth Image

The Use of Acoustic Technology for Non-DMSO, Drug Discovery Application

Thursday, 31 May 2012 at 11:15

Add to Calendar ▼2012-05-31 11:15:002012-05-31 12:15:00Europe/LondonThe Use of Acoustic Technology for Non-DMSO, Drug Discovery ApplicationSELECTBIOenquiries@selectbiosciences.com

This presentation will introduce the technology of Labcytes’ Echo-OMICS platform and some of the ways this platform is being utilized within GlaxoSmithKline. Data will be presented to demonstrate the use of this system to support non-DMSO sample handling. This will include, the dispense of antibodies for Meso-Scale Discovery (MSD) plate production within the assay development for MSD assays and by replicating data from established MSD assays at GSK. Additionally the application of this technology to reduce the volumes of biological reagents needed in crystallography studies will be discussed.


Add to Calendar ▼2012-05-30 00:00:002012-05-31 00:00:00Europe/LondonDrug Discovery Automation - Chemistry Automation and Compound ManagementSELECTBIOenquiries@selectbiosciences.com